Forest Labs Inc: (NYSE: FRX)

$39.53

2.02 (5.39%)

Volume 4,003,288

04:02 PM ET

Zacks Rank: 3-Hold

BROKERAGE REPORTS

Search for reports:

By ticker:

Search By Industry

Search By Research Provider

0 items in cart

FOREST LABS A [FRX]

Reports for Purchase

Showing records 1 - 20 ( 111 total )

Record: 1

05/07/2013

Company Report

Pages: 10

Company: FOREST LABS A
Industry: MED-DRUGS

Provider: Zacks Investment Research

Price: 24.95

Research Provided by a Third Party

Record: 2

04/24/2013

Company Report

Pages: 9

Company: FOREST LABS A
Industry: MED-DRUGS

Provider: Zacks Investment Research

Price: 24.95

Research Provided by a Third Party

Record: 3

03/04/2013

Industry Report

Pages: 16

Company: FOREST LABS A
Industry: MED-DRUGS

Biotechnology/Biopharmaceuticals/BioDefense-New Drug Launch Weekly Retail Sales Tracker - Week ending February 22, 2013

Provider: Wedbush Securities Inc.

Analyst: MARAI C

Price: 50.00

Record: 4

01/31/2013

Company Report

Pages: 10

Company: FOREST LABS A
Industry: MED-DRUGS

Provider: Zacks Investment Research

Price: 24.95

Research Provided by a Third Party

Record: 5

01/16/2013

Company Report

Pages: 9

Company: FOREST LABS A
Industry: MED-DRUGS

Provider: Zacks Investment Research

Price: 24.95

Research Provided by a Third Party

Record: 6

10/25/2012

Company Report

Pages: 10

Company: FOREST LABS A
Industry: MED-DRUGS

Provider: Zacks Investment Research

Price: 24.95

Research Provided by a Third Party

Record: 7

10/17/2012

Company Report

Pages: 9

Company: FOREST LABS A
Industry: MED-DRUGS

Provider: Zacks Investment Research

Price: 24.95

Research Provided by a Third Party

Record: 8

10/02/2012

Company Report

Pages: 10

Company: FOREST LABS A
Industry: MED-DRUGS

Provider: Zacks Investment Research

Price: 24.95

Research Provided by a Third Party

Record: 9

10/01/2012

Daily Note

Pages: 10

Company: FOREST LABS A
Industry: MED-DRUGS

Suspension of Coverage; Life''s Been Good

Provider: Robert W. Baird & Co., Inc.

Price: 25.00

Research Provided by a Third Party

Record: 10

08/22/2012

Industry Report

Pages: 9

Company: FOREST LABS A
Industry: MED-DRUGS

Biotechnology - July Institutional Script Data

Provider: Robert W. Baird & Co., Inc.

Analyst: RUSSO T

Price: 25.00

Record: 11

07/26/2012

Company Report

Pages: 10

Company: FOREST LABS A
Industry: MED-DRUGS

Provider: Zacks Investment Research

Price: 24.95

Research Provided by a Third Party

Record: 12

07/25/2012

Industry Report

Pages: 9

Company: FOREST LABS A
Industry: MED-DRUGS

June Institutional Script Data (WKH)

Provider: Robert W. Baird & Co., Inc.

Analyst: RUSSO T

Price: 25.00

Record: 13

07/19/2012

Company Report

Pages: 12

Company: FOREST LABS A
Industry: MED-DRUGS

FQ1-13 Model Updates and Wrap Up

Provider: Robert W. Baird & Co., Inc.

Analyst: RUSSO T

Price: 25.00

Record: 14

07/18/2012

Company Report

Pages: 9

Company: FOREST LABS A
Industry: MED-DRUGS

Provider: Zacks Investment Research

Price: 24.95

Research Provided by a Third Party

Record: 15

07/17/2012

Company Report

Pages: 5

Company: FOREST LABS A
Industry: MED-DRUGS

FQ1-13 First Take: Net Neutral

Provider: Robert W. Baird & Co., Inc.

Analyst: RUSSO T

Price: 10.00

Record: 16

07/12/2012

Daily Note

Pages: 37

Company: FOREST LABS A
Industry: MED-DRUGS

Biotechnology - Q2-12 Preview for Commercial-Stage Companies

Provider: Robert W. Baird & Co., Inc.

Analyst: RUSSO T

Price: 75.00

Record: 17

06/21/2012

Company Report

Pages: 9

Company: FOREST LABS A
Industry: MED-DRUGS

Investor Day 2012 and Catch-up Model Update

Provider: Robert W. Baird & Co., Inc.

Analyst: RUSSO T

Price: 25.00

Record: 18

06/20/2012

Industry Report

Pages: 9

Company: FOREST LABS A
Industry: MED-DRUGS

Biotechnology-May Institutional Script Data (WKH)

Provider: Robert W. Baird & Co., Inc.

Analyst: RUSSO T

Price: 25.00

Record: 19

06/13/2012

Company Report

Pages: 8

Company: FOREST LABS A
Industry: MED-DRUGS

Provider: Zacks Investment Research

Price: 24.95

Research Provided by a Third Party

Record: 20

05/23/2012

Industry Report

Pages: 9

Company: FOREST LABS A
Industry: MED-DRUGS

Biotechnology : April Institutional Script Data (WKH).

Provider: Robert W. Baird & Co., Inc.

Analyst: RUSSO T

Price: 25.00

Zacks Research is Reported On:

Zacks Investment Research

is an A+ Rated BBB

Accredited Business.